Legions of nanorobots target cancerous tumors with precision


Researchers have developed new nanorobotic agents capable of navigating through the bloodstream to administer a drug with precision by specifically targeting the active cancerous cells of tumours. This way of injecting medication ensures the optimal targeting of a tumour and avoids jeopardizing the integrity of organs and surrounding healthy tissues.

Image: Blood and cancerous cells; Copyright: Panthermedia.net/juras1077

Cancerous acute lymphoblastic leukaemia cells produce and release special structures that can be traced in the blood.; © Montréal Nanorobotics Laboratory

Dr Suzanne Johnson says that cancerous acute lymphoblastic leukaemia cells produce and release special structures that can be traced in the blood.

The discovery could have major implications on the diagnosis, monitoring, drug delivery and treatment of childhood leukaemia.

Until recently, the "Extracellular Vesicles", as they are known, were thought to be worthless debris. Dr Johnson investigated their presence in the plasma from bone marrow biopsies and discovered their ability to circulate in the blood using mice.

Though there is an 85 to 90% success rate in treatment, children must endure repeat bone marrow biopsies to assess the progress of treatment.

But the researchers hope this discovery might reduce the frequency of the painful procedures, which can also cause bruising, bleeding and infection.

Vesicles, which contain the protein actin and have identifiable characteristics of their parent cell, are typified by branching structures beautifully shown in images produced by the team.

Dr Johnson said: "Our discovery of Extracellular Vesicles could be a game changer in terms of the way we care for children with lymphoblastic leukaemia."

"Our research has shown that cancerous leukaemia cells have the ability to package parts of themselves and then send these structure – vesicles – to anywhere in the body though the blood. That opens up a world of possibilities in terms of monitoring the progress of the disease and making diagnosis quickly and efficiently. They are also internalised by other cells and act as an effective route for cell communication. Now the challenge is to investigate whether other cancers produce and release these structures as well."

Further down the road, the discovery could have implications on the way drugs are delivered to patients, explains to Dr Johnson, if we can find a way to combine them with the vesicles.

And the team also hope that the vesicles might provide individualised information about the tumours, eventually helping doctors to deliver personalised care.

She added: "What is amazing is that Vesicles were previously dismissed as mere debris from the cancerous cell, but we now realise this absolutely not the case. They are far more interesting than that!"

COMPAMED-tradefair.com; Source: Manchester University

More about Manchester University at: www.manchester.ac.uk